Senior Analyst
Wildan Kurniawan, MPH
Wildan is a medical doctor and public health expert, who has extensive experience working with prominent pharmaceutical companies and with shaping and implementing Indonesian health policy.
Wildan has a deep knowledge of the health care sector, which he acquired through years of professional experience. He has worked at two international medicine manufacturers, conducted research at Indonesia’s largest and most prestigious teaching hospital and served as a general practitioner.
Wildan’s comprehensive advocacy approach ensures that client initiatives to strengthen the Indonesian health care sector translate into favorable policies. He examines policy issues within the broader context of the country’s political, economic and business trends. This enables him to develop strategies that promote collaboration with industry players, health care professionals, academics and government officials to address long-standing challenges. He formulates narratives that resonate with all stakeholders while remaining aligned with client objectives, including those related to pharmaceutical and medical device policies, disease prevention and treatment guidelines and the National Health Insurance Program (JKN).
Wildan holds a master’s degree in public health from Harvard University’s T. H. Chan School of Public Health and is a graduate of the University of Indonesia’s medical school.
Insights & News
India Kicks Off World’s Largest Democratic Exercise With 2024 General Election
The BGA India Team, led by Managing Director Ratan Shrivastava, wrote an update on the …
Thai Cabinet Reshuffle Strengthens PM Srettha’s Hand
BGA Thailand Senior Adviser Thitinan Pongsudhirak wrote an update analyzing Thailand’s latest Cabinet reshuffle. Thailand’s …
Australia Announces New Foreign Investment Framework
The BGA Australia Team, led by Managing Director Michael “Mick” McNeill, wrote an update on …